Evidence map›Paper›PMID 29636600›Full record

ArticleDrug design, development and therapy2018

The apoptotic effects of

Elham Bagheri, Fatemeh Hajiaghaalipour, Shaik Nyamathulla, Nur'Ain Salehen

Open access · goldAbstract read
In one paragraph

Article in Drug design, development and therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 46 citations in OpenAlex.

  1. Review
  2. The Therapeutic Potential ofMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Exploring Bioactive Potential ofIndian journal of microbiology · 2024
    Article
  5. Article
  6. Article
  7. Article
  8. Cytotoxicity and Apoptosis Studies of Brucein D against T24 Bladder Cancer Cells.Asian Pacific journal of cancer prevention : APJCP · 2024
    Article
  9. Article
  10. Iranian journal of medical sciences · 2024
    Article
  11. Red Kale (Molecules (Basel, Switzerland) · 2023
    Article
  12. A review ofFrontiers in pharmacology · 2023
    Review
  13. Article
  14. Article
  15. Review
  16. Exopolysaccharide Produced byFoods (Basel, Switzerland) · 2021
    Article
  17. Review
  18. Translational cancer research · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Elham BagheriDepartment of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Fatemeh HajiaghaalipourInstitute of Biological Science, Faculty of Science, University of Malaya, Kuala Lumpur, Malaysia.
Shaik NyamathullaDepartment of Pharmacy, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
Nur'Ain SalehenDepartment of Biomedical Science, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
University of Malaya · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPURPOSE: In this study, we have investigated the cytotoxic effects of the

methods3-(4,5-dimethylthiazol-2-yl)-2, 5,-diphenyltetrazolium bromide (MTT), lactate dehydrogenase, acridine orange/propidium iodide, and annexin-V-fluorescein isothiocyanate assays were performed to determine the antiproliferative and apoptosis validation of BJEE on cancer cells. Measurement of reactive oxygen species (ROS) production, caspase activities, nucleus factor-κB activity, and gene expression experiments was done to investigate the potential mechanisms of action in the apoptotic process.

resultsThe results obtained from this study illustrated the significant antiproliferative effect of BJEE on colorectal cancer cells, with a concentration value that inhibits 50% of the cell growth of 25±3.1 µg/mL after 72 h of treatment. MTT assay demonstrated that the BJEE is selectively toxic to cancer cells, and BJEE induced cell apoptosis via activation of caspase-8 along with modulation of apoptosis-related proteins such as Fas, CD40, tumor necrosis factor-related apoptosis-inducing ligands, and tumor necrosis factor receptors, which confirmed the contribution of extrinsic pathway. Meanwhile, increased ROS production in treated cells subsequently activated caspase-9 production, which triggered the intrinsic pathways. In addition, overexpression of cytochrome-c, Bax, and Bad proteins along with suppression of Bcl-2 illustrated that mitochondrial-dependent pathway also contributed to BJEE-induced cell death. Consistent with the findings from this study, BJEE-induced cancer cell death proceeds via extrinsic and intrinsic mitochondrial-dependent and -independent events.

conclusionFrom the evidence obtained from this study, it is concluded that the BJEE is a promising natural extract to combat colorectal cancer cells (HT29 cells) via induction of apoptosis through activation of extrinsic and intrinsic pathways.

Indexed as

Up-RegulationAntineoplastic Agents, PhytogenicApoptosisBruceaCell ProliferationDose-Response Relationship, DrugDrug Screening Assays, AntitumorFruitHT29 CellsHumansNF-kappa BPlant ExtractsProtein TransportSignal TransductionStructure-Activity RelationshipTumor Suppressor Protein p53Antineoplastic Agents, PhytogenicNF-kappa BPlant ExtractsTumor Suppressor Protein p53apoptosisapoptosis protein arrayBrucea javanicacancerHT29mitochondrial pathway

Identifiers

PMID29636600
PMCPMC5881282
OpenAlexW2795330453

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.